NASDAQ:GRTS
Gritstone bio, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
gritstonebio.comipo date
Sep 28, 2018
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and co...Show More
Earnings
Earnings Release in 11 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus